Rapport Therapeutics (RAPP) executive compensation, 2026 proxy

Abraham Ceesay, M.B.A., Chief Executive Officer, was paid $6.3M in 2025, down 36% from $9.8M the year before.

Filed
April 23, 2026
Annual meeting
June 10, 2026
Pay year
2025
Named executives
3
CEO total pay
$6.3M-36% vs prior year
CEO Target Bonus
55%Percentage of annual base salary
CFO Target Bonus
40%Percentage of annual base salary
CMO Target Bonus
40%Percentage of annual base salary

How M.B.A. was paid

$6.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary10%Option awards82%Non-equity incentive7%All other compensation0%

Named executive officers

ExecutiveTotal
Abraham Ceesay, M.B.A.Chief Executive Officer$6,265,174
Troy IgnelziChief Financial Officer$2,506,139
Jeffrey Sevigny, M.D.Chief Medical Officer$3,023,942

What changed and why

  • $6.3MCEO Abraham Ceesay received total compensation of $6,265,174 in fiscal 2025.
  • Option awards formed the largest component of executive compensation across named executive officers.
  • Annual cash bonuses were determined based on corporate and individual performance goals.
  • 100%The company maintained matching 401(k) contributions equal to 100% of deferrals up to 4%.
  • Executives received limited perquisites primarily consisting of commuting expense reimbursements.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.